Selectis Health, Inc.: 10-K filed 2025-04-15

Name: Selectis Health, Inc.: 10-K filed 2025-04-15
Creator: Selectis Health, Inc.

What Selectis Health, Inc. reported in its annual report filed 2025-04-15 (fiscal FY 2024): 34 published measures, 70 facts as tagged in accession 0001641172-25-004859.

This filing

Form: 10-K (annual report)
Filed: 2025-04-15
Fiscal period: fiscal FY 2024
Accession: 0001641172-25-004859 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Selectis Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-12-31	33,446,964	USD
At 2023-12-31	40,671,455	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-12-31	38,857,220	USD
At 2023-12-31	43,635,250	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2024-12-31	-5,410,256	USD
At 2023-12-31	-2,963,795	USD
At 2022-12-31	952,835	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2024-12-31	680,332	USD
At 2023-12-31	1,484,599	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-2,423,961	USD	366
2023-01-01 to 2023-12-31	-3,970,982	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-1,824,437	USD	366
2023-01-01 to 2023-12-31	536,666	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	36,063	USD	366
2023-01-01 to 2023-12-31	29,805	USD	365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	39,492,012	USD	366
2023-01-01 to 2023-12-31	36,783,047	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-1,537,057	USD	366
2023-01-01 to 2023-12-31	-618,738	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	2,448,737	USD	366
2023-01-01 to 2023-12-31	-29,805	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-12-31	-20,191,636	USD
At 2023-12-31	-17,745,175	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	3,067,059	shares	366
2023-01-01 to 2023-12-31	3,054,587	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	3,067,059	shares	366
2023-01-01 to 2023-12-31	3,054,587	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-0.8	USD/shares	366
2023-01-01 to 2023-12-31	-1.31	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-0.8	USD/shares	366
2023-01-01 to 2023-12-31	-1.31	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2024-12-31	28,128,004	USD
At 2023-12-31	33,817,718	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-2,729,198	USD	366
2023-01-01 to 2023-12-31	-8,960,419	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-12-31	3,530,418	USD
At 2023-12-31	4,956,705	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2024-12-31	19,627,458	USD
At 2023-12-31	18,146,065	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit
At 2024-12-31	1,076,908	USD
At 2023-12-31	1,076,908	USD
At 2022-12-31	1,076,908	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2024-12-31	2,616,929	USD
At 2023-12-31	2,091,536	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	42,221,210	USD	366
2023-01-01 to 2023-12-31	45,743,466	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2024-12-31	3,067,059	shares
At 2023-12-31	3,067,059	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2024-12-31	13,852,028	USD
At 2023-12-31	13,852,028	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2024-12-31	42,987,050	USD
At 2023-12-31	47,696,168	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2024-12-31	14,859,046	USD
At 2023-12-31	13,878,450	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2024-12-31	233,157	USD
At 2023-12-31	1,380,570	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-2,446,461	USD	366
2023-01-01 to 2023-12-31	-4,000,982	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	9,249,718	USD	366
2023-01-01 to 2023-12-31	9,968,188	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	103,432	USD	366
2023-01-01 to 2023-12-31	347,783	USD	365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	2,046,887	USD	366
2023-01-01 to 2023-12-31	2,173,763	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	239,981	USD	366
2023-01-01 to 2023-12-31	296,442	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	305,237	USD	366
2023-01-01 to 2023-12-31	4,989,437	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	1,749,183	USD	366
2023-01-01 to 2023-12-31	1,782,489	USD	365

Inspect the source

Entity: Selectis Health, Inc. / CIK 0000727346
Captured: 2026-09-19T15:00:26.408Z
SEC response SHA-256: 98084fe11a07b9229eef60550e570fcfec8f48e5c4750b74ebaa187a5d31ada2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000727346.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))